Marco A. Peña Duque – President, Mexican Society of Cardiology
The president of the Mexican Society of Cardiology sat down with us to share his view of the cardiology medical field in the country, why Mexico needs to collaborate more…
Address: Avenida Paseo del Pacifico No. 410, Technology Park, C.P. 45010, Carretera a Nogales km 13.5, Zapopan, Jalisco, México
,Mexico
Tel: +52 33 3777 4770
Web: http://www.gelpharma.com/
Gelpharma began operations in Mexico in 1999 as a high-tech pharmaceutical company; the result of the integration of 100% Mexican private capital. Focused primarily on the manufacturing of soft gelatin capsules under the strictest quality standards, Gelpharma has gained wide recognition in both the public and private sector. At present, Gelpharma has two soft gel manufacturing plants installed in Jocotán (Jalisco) and Guadalajara Technology Park, both equipped with the most advanced pharmaceutical technology, and thanks to its steady growth, has expanded distribution of its products to Central and South America.
High quality soft-gel capsules
The president of the Mexican Society of Cardiology sat down with us to share his view of the cardiology medical field in the country, why Mexico needs to collaborate more…
Novartis strives for “creating solutions for patients that go beyond the pill”. The country head and next president of CANIFARMA discusses how the company is using new programs and technology…
Considered one of the leading medical authorities in the country, David Kershenobich provides an overview about the new challenges faced by the Mexican healthcare system with the transition from infectious…
Thanks to the recognition COFEPRIS received from the Pan-American Health Organization as national regulatory authority of regional reference, Mexican manufacturers are increasingly eyeing foreign markets to grow. The general manager…
Healthcare is one of the next items on President Peña Nieto’s busy agenda. The objective: moving Mexico towards universal healthcare coverage. The initiative was started at the beginning of 2000…
Mexico is improving its regulatory framework for orphan drugs. The general manager of Alexion Mexico explains how the company is working with the authorities to ensure adequate regulation is put…
Dr. José Angel Cordova Villalobos shares his experience as former Minister of Health and illustrates how the unification of today’s fragmented healthcare system is the only way to provide effective…
The opening of the Mexican Social Security Institute (IMSS) to clinical research is a unique opportunity for Mexico to step up on the international scenario for clinical trials. The CEO of…
Store brands are Perrigo’s core business. The vice president and managing director of the Mexican and Latin American affiliate discusses the company’s pioneer and early vision to bet on generics…
The executive director of the university spin-off UDIMEB explains the major achievements of the institution, her plans to convert it into a strategic partner to the pharmaceutical and biotechnology industry to…
The partner and leader of the healthcare practice for Mexico and Hispanic America shares his vision about how Mexico’s healthcare sector is converging to look at innovative ways to understand…
Healthcare should not be seen as an expenditure, but rather as an investment. Mexico’s former minister of health and current dean at the Harvard T.H. Chan School of Public Health…
See our Cookie Privacy Policy Here
